NCT04410367 2025-07-20
PURSUE
Blue Earth Diagnostics
Phase 2 Completed
Clinical Trials
5 trialsNCT02798406 2021-07-15
CAPTIVE
DNAtrix, Inc.
Phase 2 Completed
NCT02971319 2018-01-26
Technical Performance Assessment of Tc-99m Tetrofosmin for Differentiation of Recurrence vs Radiation Necrosis in Patients With Glioma
Proactina S.A.
Phase 2 Completed
NCT01898273 2015-09-09
Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma
Cellectar Biosciences, Inc.
Phase 2 Terminated
NCT00660283 2010-01-20
KARE003
Kentuckiana Cancer Institute
Phase 2 Unknown